In a 2017 review, it was noted that this peptide has reduced the appearance of wrinkles by around 12% (11.64% to be exact) in human subjects
Prescribers should document their clinical rationale, including the absence of contraindications, in the patient's medical record
The EMPA-REG OUTCOME trial demonstrated a 14% reduction in major adverse cardiovascular events and a 35% reduction in HF hospitalizations
Raw mass spectrometry data were processed using MS-DIAL and commercial software packages from AB Sciex (Canada), including MarkView, MasterView, PeakView, and MultiQuant
Cell turnover slows
The system helps you identify what's working and suggests adjustments - whether that means increasing frequency, combining with other peptides, or switching from topical to injectable for better results